Legal & General Group
PROK icon

Legal & General Group’s ProKidney PROK Stock Holding History

Legal & General Group’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.1K Buy
+7,410
New +$13.6K ﹤0.01% 3221
2025
Q2 		– Sell
-10,925
Closed -$9.57K – 3509
2025
Q1 		$9.57K Hold
10,925
– – ﹤0.01% 3180
2024
Q4 		$18.5K Hold
10,925
– – ﹤0.01% 3050
2024
Q3 		$21K Buy
10,925
+3,987
+57% +$9.05K ﹤0.01% 3027
2024
Q2 		$17.1K Buy
6,938
+2,933
+73% +$7.87K ﹤0.01% 3088
2024
Q1 		$6.57K Sell
4,005
-1,661
-29% -$2.44K ﹤0.01% 3266
2023
Q4 		$10.1K Sell
5,666
-20,456
-78% -$43.9K ﹤0.01% 3234
2023
Q3 		$120K Sell
26,122
-2,313
-8% -$22.1K ﹤0.01% 2808
2023
Q2 		$318K Buy
28,435
+19,435
+216% +$207K ﹤0.01% 2612
2023
Q1 		$102K Buy
9,000
+714
+9% +$7.6K ﹤0.01% 2771
2022
Q4 		$56.8K Buy
+8,286
New +$79.2K ﹤0.01% 2930

Other funds holding PROK

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $542M AUM 206.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Legal & General Group's PROK Position: Q2 2026 in Review

Legal & General Group opened a new position in ProKidney (PROK) in Q2 2026: 7,410 shares worth $15.1K. The stake represents ﹤0.01% of the portfolio and ranks #3221 among its holdings. This is a return to the name: Legal & General Group previously reported a position in PROK as recently as Q1 2025.

Legal & General Group first reported a position in PROK in Q4 2022 and has held it in 11 quarters since. The position peaked at $318K in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q2 2026.

  • Legal & General Group held 7,410 shares of ProKidney worth $15.1K as of Q2 2026.
  • ProKidney was a new Legal & General Group position in Q2 2026.
  • ProKidney made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3221 holding.
  • Legal & General Group first reported a position in ProKidney in Q4 2022 and has held it in 11 quarters since.
  • Legal & General Group's ProKidney position peaked at $318K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.